Bleeding in Patients With Atrial Fibrillation-Reply.

Ray, Wayne A; Stein, C Michael; Murray, Katherine T

Ray, Wayne A; Stein, C Michael; Murray, Katherine T.

Affiliation

Ray WA; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
Stein CM; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
Murray KT; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.

JAMA ; 332(11): 934, 2024 Sep 17.

Article in En | MEDLINE | ID: mdl-39158900

Subject(s)

Anticoagulants; Atrial Fibrillation; Hemorrhage; Humans; Anticoagulants/administration & dosage; Anticoagulants/adverse effects; Atrial Fibrillation/complications; Atrial Fibrillation/drug therapy; Hemorrhage/chemically induced; Hemorrhage/epidemiology; Stroke/etiology; Stroke/prevention & control; Sex Factors; Male; Female; Administration, Oral; Diltiazem/administration & dosage; Diltiazem/adverse effects; Drug Interactions; Rivaroxaban/administration & dosage; Rivaroxaban/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Hemorrhage / Anticoagulants Limits: Female / Humans / Male Language: En Journal: JAMA Year: 2024 Document type: Article

Fulltext

XML

PubMed Links

Search on Google